Overview

Single Dose Study of SHR4640 in Healthy Subjects

Status:
Completed

Trial end date:
2017-02-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to assess the safety, tolerance, food effect, pharmacokinetic and pharmacodynamic properties of single dose adminstration of SHR4640 in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.